References and Notes
For leading reviews, see for example:
1a
Aparicio JF.
Mendes MV.
Anton N.
Recio E.
Martin JF.
Curr. Med. Chem.
2004,
11:
1645
1b
Zotchev SB.
Curr. Med. Chem.
2003,
10:
211
1c
Rychnovsky SD.
Chem. Rev.
1995,
95:
2021
1d
Kerridge D.
Drugs Today
1988,
24:
705
1e
Crandall LW.
Hamill RL.
Bacteria
1986,
9:
355
1f
Omura S.
Tanaka H.
Macrolide Antibiotics: Chemistry, Biology and Practice
Academic Press;
New-York:
1984.
2
Zhanel GG.
Dueck M.
Hoban DJ.
Vercaigne LM.
Embil JM.
Gin AS.
Karlowsky JA.
Drugs
2001,
61:
443
3a
Pettit GR.
Cichacz ZA.
Gao F.
Herald CL.
Boyd MR.
Schmidt JM.
Hooper JNA.
J. Org. Chem.
1993,
58:
1302
3b
Pettit GR.
Cichacz ZA.
Gao F.
Herald CL.
Boyd MR.
J. Chem. Soc., Chem. Commun.
1993,
1166
4
D’Ambrosio M.
Guerriero A.
Debitus C.
Pietra F.
Helv. Chim. Acta
1996,
79:
51
For illustrative examples, see:
5a
Mickel SJ.
Niederer D.
Daeffler R.
Osmani A.
Kuesters E.
Schmid E.
Schaer K.
Gamboni R.
Chen W.
Loeser E.
Kinder FR.
Konigsberger K.
Prasad K.
Ramsey TM.
Repic O.
Wang RM.
Florence G.
Lyothier I.
Paterson I.
Org. Process Res. Dev.
2004,
8:
122
5b
Yeung KS.
Paterson I.
Chem. Rev.
2006,
in press
5c
Turks M.
Huang X.
Vogel P.
Chem. Eur. J.
2005,
11:
465
5d
Turks M.
Fonquerne F.
Vogel P.
Org. Lett.
2004,
6:
1053
5e
Gerber-Lemaire S.
Ainge SW.
Glanzmann C.
Vogel P.
Helv. Chim. Acta
2002,
85:
417
5f
Narkevitch V.
Schenk K.
Vogel P.
Angew. Chem. Int. Ed.
2000,
39:
1806
5g
Marchionni C.
Vogel P.
Helv. Chim. Acta
2001,
84:
431
5h
Sevin A.-F.
Vogel P.
J. Org. Chem.
1994,
59:
5920
6a
Schwenter ME.
Vogel P.
Chem. Eur. J.
2000,
6:
4091
6b
Schwenter ME.
Vogel P.
J. Org. Chem.
2001,
66:
7869
6c
Meilert K.
Pettit GR.
Vogel P.
Helv. Chim. Acta
2004,
87:
1493
6d
Coste G.
Gerber-Lemaire S.
Tetrahedron: Asymmetry
2005,
16:
2277
6e
Vogel P.
Gerber-Lemaire S.
Carmona Asenjo AT.
Meilert K.
Schwenter ME.
Pure Appl. Chem.
2005,
131
7a
Csákӱ AG.
Vogel P.
Tetrahedron: Asymmetry
2000,
11:
4935
7b
Gerber-Lemaire S.
Vogel P.
Eur. J. Org. Chem.
2003,
2959
8
Meilert KT.
Schwenter ME.
Shatz Y.
Dubbaka SR.
Vogel P.
J. Org. Chem.
2003,
68:
2964
9
Gerber-Lemaire S.
Carmona AT.
Meilert KT.
Vogel P.
Eur. J. Org. Chem.
2006,
in press
For other recent approaches toward polyketide macrolides, see:
10a
Kohli RM.
Burke MD.
Tao J.
Walsh CT.
J. Am. Chem. Soc.
2003,
125:
7160
10b
Schmidt DR.
Kwon O.
Schreiber SL.
J. Comb. Chem.
2004,
6:
286
10c
Beeler AB.
Acquilano DE.
Su Q.
Yan F.
Roth BL.
Panek JS.
Porco JA.
J. Comb. Chem.
2005,
7:
673
10d
Zacuto MJ.
Leighton JL.
Org. Lett.
2005,
7:
5525
11
Analytical Data for 11.
A 1:1 mixture of diastereoisomers. IR (film): 3420, 2940, 2600, 2500, 1580, 1555, 1455, 1385, 1080, 1035, 740, 700 cm-1. 1H NMR (400 MHz, MeOD): δ = 6.71-6.10 (m, 10 H), 4.52, 4.48 (2 d, 4 H, 2
J = 5.6 Hz), 4.35, 4.33 (2 d, 4 H, 2
J = 8.0 Hz), 3.98 (m, 1 H), 3.76 (m, 1 H), 3.51 (t, 2 H, 3
J = 5.2 Hz), 3.46-3.22 (m, 4 H), 3.22, 3.21, 3.19, 3.18 (4 s, 12 H), 3.64-2.31 (2 m, 2 H), 1.96-1.56 (m, 12 H) ppm. 13C NMR (100 MHz, MeOD): δ = 179.3, 139.3, 129.4, 128.9, 128.7, 95.4, 76.5, 76.2, 74.5, 74.4, 70.8, 59.4, 56.3, 43.9, 43.8, 42.0, 41.6, 40.7, 39.3, 39.2, 43.8 ppm. MALDI-MS: 673.7 [M + Na], 689.7 [M + K]. HRMS: m/z calcd for C35H54O11 + Na: 673.3564; found 673.3561.
12
Inanaga J.
Hirata K.
Saeki H.
Katsuki T.
Yamagushi M.
Bull. Chem. Soc. Jpn.
1979,
52
13
Preparation and Analytical Data for Compounds 12 and 13.
seco-Acid 11 (10 mg, 0.015 mmol) was dissolved in 1 mL of MeCN. A solution of (i-Pr)2NEt in benzene (0.4 M, 1.1 mL, 0.460 mmol, 30 equiv) and a solution of 2,4,6-trichloro-benzoyl chloride in benzene (0.4 M, 770 µL, 0.307 mmol, 20 equiv) were added. The resulting mixture was stirred at 25 °C for 3 h before being diluted with 9 mL of benzene. This mixture was added via a syringe pump to a refluxing solution of DMAP (315 mg, 2.55 mmol, 50 equiv) in 18 mL of benzene over 7 h. The reaction mixture was poured into a sat. aq solution of NaHCO3 (15 mL) and extracted with EtOAc (15 mL, 3 times). The combined organic extracts were washed with brine (10 mL), dried over MgSO4 and concentrated in vacuo. Purification of the residue by flash chromatography (MeOH-CH2Cl2, 3:97) afforded 12 and 13 as a pale yellow oil (9.5 mg, 100%).
IR (film): 2930, 1730, 1650, 1580, 1455, 1385, 1280, 1165, 1100, 860 cm-1. 1H NMR (400 MHz, C6D6): δ = 7.35-7.27 (m, 6 H), 7.12-7.08 (m, 4 H), 4.79, 4.76 (2 d, 4 H, 2
J = 6.8 Hz), 4.63, 4.57 (2 s, 4 H), 4.42-4.38 (m, 1 H), 4.32-4.23 (2 m, 1 H), 4.06-4.04 (m, 1 H), 3.63-3.39 (m, 4 H), 3.15-3.12 (m, 12 H), 2.69-2.40 (m, 2 H), 2.09-1.47 (m, 12 H) ppm. 13C NMR (100 MHz, C6D6): δ = 170.3, 138.7, 138., 128.4, 128.0, 127.7, 94.1, 93.7, 93.5, 75.8, 75.7, 75.6, 75.5, 74.7, 74.4, 72.7, 72.3, 71.8, 71.4, 69.6, 69.5, 60.7, 60.6, 56.4, 56.3, 56.2, 56.1, 55.9, 55.8, 55.7, 41.2, 39.8, 40.6, 39.4, 38.8, 38.4, 37.9, 36.8 ppm. MALDI-MS: m/z = 655.75 [M + Na], 671.72 [M + K]. Anal. Calcd for C35H52O10: C, 66.40; H, 8.33. Found: C, 66.63; H, 8.39.
14a
Aspinall IH.
Cowley PM.
Mitchell G.
Raynor CM.
Stoodley RJ.
J. Chem. Soc., Perkin Trans. 1
1999,
2591
14b
Harcken C.
Martin SF.
Org. Lett.
2001,
3:
3591
15
Preparation and Analytical Data for Compound 18.
seco-Acid 17 (32 mg, 0.052 mmol) was dissolved in 1 mL of MeCN. A solution of (i-Pr)2NEt in benzene (0.4 M, 3.9 mL, 1.55 mmol, 30 equiv) and a solution of 2,4,6-trichloro-benzoyl chloride in benzene (0.4 M, 2.6 mL, 1.05 mmol, 20 equiv) were added. The resulting mixture was stirred at 25 °C for 3 h before being diluted with 12.5 mL of benzene. This mixture was added via a syringe pump to a refluxing solution of DMAP (315 mg, 2.55 mmol, 50 equiv) in 25 mL of benzene over 6 h. The reaction mixture was poured into H2O (30 mL) and extracted with EtOAc (30 mL, 3 times). The combined organic extracts were dried over MgSO4 and concentrated in vacuo. Purification of the residue by flash chromatography (2% of MeOH in CH2Cl2) afforded 18 as a pale yellow oil (15 mg, 49%). IR (film): 3420, 2930, 1735, 1580, 1450, 1375, 1275, 1160, 1120, 1040, 740, 700 cm-1. 1H NMR (400 MHz, MeOD): δ = 7.35-7.27 (m, 10 H), 4.77-4.74, 4.68-4.66 (2 m, 4 H), 4.66-4.59 (m, 4 H), 4.56-4.52 (m, 2 H), 4.05-3.87 (m, 6 H), 2.40-2.30 (m, 2 H), 2.10-1.90 (2 m, 16 H) ppm. 13C NMR (100 MHz, MeOD): δ = 164.3, 138.3, 138.2, 128.4, 128.0, 127.7, 94.5, 94.3, 75.2, 73.4, 69.8, 69.2, 67.1, 66.9, 64.9, 58.5, 45.3, 45.0, 44.9, 43.6, 42.8, 38.4, 38.3, 34.7, 20.6 ppm. MALDI-MS: m/z = 627.10 [M + Na], 643.06 [M + K]. HRMS: m/z calcd for C33H48O10 + Na: 627.3145; found: 627.3142.
16
Preparation and Analytical Data for Compound 20.
To a solution of 19 (245 mg, 0.371 mmol) in 2 mL of dry CH2Cl2, were added 4 Å MS (185 mg), 4-methylmorpholine N-oxide (105 mg, 0.778 mmol, 2.1 equiv) and tetrapropyl-ammonium perruthenate (13 mg, 0.037 mmol, 0.1 equiv). The mixture was stirred at 25 °C for 1 h and then filtered over a pad of Celite®. The solvent was removed under reduced pressure and filtration of the residue over a short pad of silica (6% MeOH in CH2Cl2) afforded the corresponding dialdehyde as a brown oil. Triphenylphosphonium methyl bromide (450 mg, 1.256 mmol, 5 equiv) was dissolved in 2 mL of anhyd THF. The mixture was cooled at -78 °C and n-BuLi (1.5 M in THF, 800 µL, 1.256 mmol, 5 equiv) was added dropwise. The solution was warmed to 25 °C for 45 min. A solution of the crude dialdehyde in THF (1 mL) was added to the resulting yellow mixture at -78 °C. At the end of the addition the cooling bath was removed and the reaction mixture was stirred for 3 h at 25 °C. The mixture was poured into H2O (15 mL) and extracted with EtOAc (20 mL, 3 times). The combined organic extracts were washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. Purification of the residue by flash chromatography (EtOAc-PE, 1:7) afforded 20 as a colorless oil (75 mg, 31% over two steps). IR (film): 2940, 1640, 1440, 1390, 1100, 1040, 915, 740, 700 cm-1. 1H NMR (400 MHz, MeOD):
δ = 7.35-7.27 (m, 10 H), 5.85 (ddd, 2 H, 3
J = 17.2, 10.0, 6.0 Hz), 5.08 (d, 2 H, 3
J = 17.2 Hz), 5.03 (d, 2 H, 3
J = 10.0 Hz), 4.82, 4.78 (2 d, 4 H, 2
J = 6.0, 7.0 Hz), 4.63, 4.61 (2 d, 4 H, 2
J = 5.2, 4.9 Hz), 4.12-3.92 (m, 4 H), 3.91-3.88, 3.87-3.78 (2 m, 4 H), 2.34, 2.32 (2 dd, 4 H, 3
J = 6.4, 5.6 Hz), 1.62-1.37 (m, 10 H), 1.33, 1.29, 1.27 (3 s, 12 H) ppm. 13C NMR (100 MHz, MeOD): δ = 138.4, 138.3, 134.8, 128.4, 127.8, 127.7, 116.7, 100.5, 98.8, 94.5, 94.2, 75.2, 74.1, 69.7, 69.6, 66.0, 65.8, 63.7, 63.3, 43.3, 42.3, 42.1, 40.0, 39.9, 38.6, 37.5, 29.5, 19.2, 24.4, 24.3 ppm. MALDI-MS: m/z = 675.441 [M + Na]. Anal Calcd for C39H56O8: C, 71.75; H, 8.65. Found: C, 71.78; H, 8.67.
17a
Evano G.
Schaus JV.
Panek JS.
Org. Lett.
2004,
6:
525
17b
Lee CW.
Grubbs RH.
Org. Lett.
2000,
2:
2145
18
Analytical Data for 21.
IR (film): 3415, 2935, 1640, 1435, 1375, 1100, 1035, 915, 740, 695 cm-1. 1H NMR (400 MHz, MeOD): δ = 7.35-7.27 (m, 10 H), 5.88-5.82 (m, 2 H), 5.11-5.03 (m, 4 H), 4.83 (s, 4 H), 4.64, 4.62 (2 s, 4 H,), 4.10-3.95 (m, 6 H), 2.39-2.33 (m, 4 H), 1.62-1.50 (m, 10 H) ppm. 13C NMR (100 MHz, MeOD): δ = 138.3, 134.9, 134.8, 128.4, 128.0, 127.7, 116.7, 94.2, 75.0, 74.8, 69.8, 69.7, 69.2, 67.1, 66.8, 64.7, 45.3, 45.0, 44.9, 43.0, 42.6, 39.9, 39.8 ppm. MALDI-MS: m/z = 573.84 [M + Na].
19
Preparation and Analytical Data for 22.
To a solution of 21 (25 mg, 0.044 mmol) in dry CH2Cl2 (25 mL, 0.002 mM), tricyclohexylphosphine [1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene][benzyl-idine] ruthenium(IV) dichloride (7.5 mg, 8.731 µmol, 0.2 equiv) was added. The resulting pink solution was heated at 50 °C for 7 h. The solvent was removed under reduced pressure and the residue was filtered on a pad of silica (3-10% MeOH in CH2Cl2) affording a brown oil that was dissolved in EtOAc (2 mL) and treated with a catalytic amount of palladium (10% on activated charcoal) under 1 atm of H2. After 1 h at 25 °C, the resulting mixture was filtered over a pad of Celite®. Removal of the solvent under reduced pressure and purification of the residue was by flash chromatography (3-10% MeOH in CH2Cl2) afforded 22 as a pale yellow oil (7.5 mg, 32%). IR (film): 3410, 2940, 2515, 1425, 1380, 1165, 1100, 1040, 740, 700 cm-1. 1H NMR (400 MHz, MeOD): δ = 7.34-7.25 (m, 20 Harom), 4.79 (s, 8 H), 4.58 (s, 8 H), 4.10-3.90 (m, 8 H), 3.90-3.80 (m, 4 H), 1.80-1.50 (m, 28 H), 1.50-1.35 (m, 8 H) ppm. 13C NMR (100 MHz, MeOD): δ = 138.4, 128.4, 127.9, 127.7, 94.2, 94.1, 93.9, 75.4, 75.2, 75.1, 75.0, 69.7, 69.6, 68.3, 68.2, 66.8, 66.7, 66.6, 66.5, 65.1, 64.9, 45.4, 45.3, 45.1, 45.0, 44.9, 42.8, 42.7, 42.1, 42.0, 37.8, 34.9, 25.1, 25.0, 24.9, 24.8 ppm. MALDI-MS: m/z = 1116.35 [M + Na], 1131.36 [M + K]. HRMS: m/z calcd for C62H92O16 + Na: 1115.6283; found: 1115.6287. Anal. Calcd for C62H92O16: C, 68.11; H, 8.51. Found: C, 68.00; H, 8.48.